TSTrisha Sunderajan

Trisha Sunderajan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Trisha Sunderajan has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Harmanpreet S. Chawla

    Division of Pediatric Critical Care, Department of Pediatrics, Loma Linda University School of Medicine, Loma Linda University Children’s Hospital, Loma Linda, CA 92354, USA

    3 shared publications
  • Harsha K. Chandnani

    Division of Pediatric Critical Care, Department of Pediatrics, Loma Linda University School of Medicine, Loma Linda University Children’s Hospital, Loma Linda, CA 92354, USA

    3 shared publications
  • Robert D. Guglielmo

    Division of Pediatric Critical Care, Department of Pediatrics, Loma Linda University School of Medicine, Loma Linda University Children’s Hospital, Loma Linda, CA 92354, USA

    3 shared publications
  • Caroline La Ferla

    Department of Pediatrics, Loma Linda University School of Medicine, Loma Linda University Children’s Hospital, Loma Linda, CA 92354, USA

    2 shared publications
  • Da-Eun (Shira) Choi

    Department of Pediatrics, Loma Linda University School of Medicine, Loma Linda University Children’s Hospital, Loma Linda, CA 92354, USA

    2 shared publications
  • Michael E. Giang

    Division of Pediatric Critical Care, Department of Pediatrics, Loma Linda University School of Medicine, Loma Linda University Children’s Hospital, Loma Linda, CA 92354, USA

    2 shared publications

Latest Publications

  • Open Access

    Predictors and Outcomes of Bronchodilator Use in Critical Bronchiolitis

    by Trisha Sunderajan, Robert D. Guglielmo, Harsha Chandnani, Harmanpreet S. Chawla

    Objective: The role of bronchodilators in bronchiolitis remains unclear, yet they are commonly used. We evaluated their impact in children based on family history of atopy and viral etiology (RSV and rhinovirus). Methods: This was a single-center, retrospective study of children ≤ 2 years admitted to the PICU, step-down ICU, or cardiothoracic ICU who required high-flow nasal cannula, non-invasive ventilation, or invasive ventilation. Patients were categorized by bronchodilator use and stratified by family history of atopy. Primary outcomes were ICU and hospital length of stay (LOS) and length of respiratory support (LRS). The Critical Bronchiolitis Score (CBS) was used to adjust for illness severity by calculating predicted outcomes and comparing them with the observed values. Secondary analysis evaluated outcomes based on family history of atopy and RSV/ rhinovirus positivity. Results: Of 105 included patients, 56 (53.3%) received bronchodilators. The no-bronchodilator group had shorter ICU-LOS (1.7 vs. 2.5 days; p = 0.0005) and hospital LOS (2.1 vs. 3.4 days; p = 0.0038) compared to the bronchodilator group. Predicted ICU outcomes did not differ between groups. Secondary analyses suggested differences in ICU-LOS (p = 0.007) and hospital LOS (p = 0.02) based on family history of atopy. In rhinovirus-positive patients, both ICU and hospital LOS were shorter without bronchodilators, while no differences were observed in RSV-positive patients. Conclusions: Bronchodilators in critical bronchiolitis were associated with longer inpatient LOS, despite similar predicted illness severity. Neither a family history of atopy nor rhinovirus/RSV positivity affected bronchodilator outcomes. Future prospective research is needed to identify targeted subgroups of patients who may benefit from this therapy.

  • Open Access

    Routine Chest X-Rays in Critical Bronchiolitis Do Not Improve Outcomes

    by Trisha Sunderajan, Da-Eun (Shira) Choi, Caroline LaFerla, Robert D. Guglielmo, Harsha K. Chandnani, Michael C. Mount, Harmanpreet S. Chawla, Michael E. Giang

    Background: Routine chest X-rays (CXR) are not recommended by the American Academy of Pediatrics in bronchiolitis, yet remain a mainstay in diagnostics. We aimed to understand the impact of obtaining CXRs in patients with critical bronchiolitis, assessing intensive care unit length of stay (ICU-LOS) and intensive care unit level of respiratory support (ICU-LRS). Methods/Design: This single-center retrospective cohort study assessed children less than three years of age admitted to the PICU, pediatric step-down ICU, and pediatric cardiac ICU. Two groups were used for analysis: patients with CXR and no-CXR. The primary outcome was the difference in ICU-LOS and ICU-LRS between the groups. The critical bronchiolitis score (CBS) was used to calculate a predicted ICU-LOS and ICU-LRS. The secondary outcome was the difference between actual and predicted ICU-LOS and ICU-LRS, comparing the groups. Results: Of the 107 patients included, 65 patients (61%) received a CXR. Patients who received a CXR had significantly longer ICU-LOS (p = 0.01) and ICU-LRS (p = 0.02), despite no difference in predicted illness severity (ICU-LOS, p = 0.4; ICU-LRS, p = 0.3). The difference between actual and predicted ICU-LOS was greater in the no-CXR group (–1.4 days) compared to the CXR group (–0.8 days; p = 0.04). A similar trend was observed in ICU-LRS (–0.1 vs. –0.6 days; p = 0.1), though not statistically significant. Conclusions: Routine CXRs are common in critically ill bronchiolitis patients and may be associated with longer ICU-LOS and ICU-LRS, despite similar illness severity.


  • Open Access

    Routine Chest X-Rays in Critical Bronchiolitis Do Not Improve Outcomes

    by Trisha Sunderajan, Shira Choi, Caroline La Ferla, Robert Guglielmo, Harsha Chandnani, Michael C. Mount, Harmanpreet S. Chawla, Michael E. Giang

    Background: Routine chest X-rays (CXR) are not recommended by the American Academy of Pediatrics in bronchiolitis, yet remain a mainstay in diagnostics. We aimed to understand the impact of obtaining CXRs in patients with critical bronchiolitis, assessing intensive care unit length of stay (ICU-LOS) and intensive care unit level of respiratory support (ICU-LRS). Methods/Design: This single-center retrospective cohort study assessed children less than three years of age admitted to the PICU, pediatric step-down ICU, and pediatric cardiac ICU. Two groups were used for analysis: patients with CXR and no-CXR. The primary outcome was the difference in ICU-LOS and ICU-LRS between the groups. The critical bronchiolitis score (CBS) was used to calculate a predicted ICU-LOS and ICU-LRS. The secondary outcome was the difference between actual and predicted ICU-LOS and ICU-LRS, comparing the groups. Results: Of the 107 patients included, 65 patients (61%) received a CXR. Patients who received a CXR had significantly longer ICU-LOS (p = 0.01) and ICU-LRS (p = 0.02), despite no difference in predicted illness severity (ICU-LOS, p = 0.4; ICU-LRS, p = 0.3). The difference between actual and predicted ICU-LOS was greater in the no-CXR group (–1.4 days) compared to the CXR group (–0.8 days; p = 0.04). A similar trend was observed in ICU-LRS (–0.1 vs. –0.6 days; p = 0.1), though not statistically significant. Conclusion: Routine CXRs are common in critically ill bronchiolitis patients and may be associated with longer ICU-LOS and ICU-LRS, despite similar illness severity.